Go to deals
Healthcare | Private Equity

ERBC (ex CERB) has acquired RTC

The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).

ERBC provides healthcare and chemical professionals a comprehensive range of experimental capabilities and services, from preclinical proof-of-concept to market of any type of drug candidate or chemical compound. Each project is managed by a study director, relying on a multi-disciplinary team of experts, notably in general pharmacology, cardiology, electrophysiology and pathophysiology, and also benefiting from a world-class academic and private network.

RTC is a fully fledged contract research laboratory located near Rome, Italy, with a track record spanning more than four decades. RTC collaborates with a large range of industrial clients including the pharmaceutical, biotech, chemical, agro-chemical and biocide industries.

Oaklins' team in France advised the buyer in this transaction.

Parties
“With the help of Oaklins, we are thrilled to join forces and offer a critical mass of credible and efficient alternative to the big CROs. We are proud to be a unique European player in the field. Our partnerships with the pharma, other CROs and independent experts play a key role in driving improvements in the pharmaceutical and chemical industries, delivering better data to regulators as well as improved value to study sponsors. Oaklins' team gave us fantastic support in a complex transaction.”

Serge Richard

CEO, ERBC

Talk to the deal team

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Private Equity | Business Support Services | Construction & Engineering Services

Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth

Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.

Learn more
Nuzoa has acquired Agrofauna
Private Equity | Consumer & Retail

Nuzoa has acquired Agrofauna

Nuzoa, a provider of value-added services for pets and livestock in the Iberian Peninsula, has acquired 100% of Agrofauna. This transaction reinforces Nuzoa’s presence in the Portuguese market, particularly in the northern region, marking another step toward its ambition to become the leading operator while further consolidating its brand across Iberia.

Learn more